Deep Dives FuelCell Energy (FCEL) Q1 Loss Narrows to $0.52/Share vs $0.68 Estimate, Revenue Misses by 29.5% 1 month ago FuelCell Energy narrows Q1 loss to $0.52/share vs $0.68 estimate, but revenue of $30.5M misses $43.3M consensus by 29.5% on… Yalla Group (YALA) Q4 Earnings Flat at $0.21 EPS, $83.9M Revenue Signals Growth Stall 1 month ago Yalla Group's Q4 adjusted EPS of $0.21 and revenue of $83.9M matched the prior quarter exactly, signaling a growth plateau. Brilliant Earth (BRLT) Posts Q4 Loss Despite Record $124.4M Revenue and 34% Booking Surge 1 month ago Brilliant Earth posts Q4 loss of $0.06/share on record revenue of $124.4M as fine jewelry bookings surge 34% despite metal… Olaplex Reports Q4 Revenue of $105.1M as Beauty Company Sets Sights on $435M in 2026 1 month ago Olaplex posted Q4 adjusted EPS of $0.01, meeting estimates, with revenue of $105.1M and full-year 2026 guidance of $414M-$435M. Myers Industries (MYE) Q4 Earnings: $0.31 EPS Beats on 230 Basis Point Margin Expansion 1 month ago Myers Industries posted Q4 adjusted EPS of $0.31 with revenue of $204M, expanding operating margin 230 basis points as transformation… Capital Clean Energy Carriers (CCEC) Posts Q4 EPS of $0.48 on $98.3M Revenue 1 month ago Capital Clean Energy Carriers reports Q4 adjusted EPS of $0.48 on revenue of $98.3 million, with net income of $28.4… Kura Oncology Posts $0.92/Share Q4 Loss as KOMZIFTI Launch Delivers $2.1M in Initial Revenue 1 month ago Kura Oncology reports wider Q4 loss of $0.92/share as KOMZIFTI launch generates $2.1M in first weeks; payers implement step edits… Autohome (ATHM) Q4 Earnings Meet Estimates at $0.09 EPS as AI Transformation and Mall Launch Drive Transaction Strategy 1 month ago Autohome reports Q4 adjusted EPS of $0.09 matching estimates on revenue of $209.1M as AI-driven transformation and Autohome Mall launch… Global Ship Lease (GSL) Q4 Earnings: Adjusted EPS at $2.32 on $190.9M Revenue 1 month ago Global Ship Lease reports Q4 adjusted EPS of $2.32 and revenue of $190.9M, with adjusted EPS up 9.41% year-over-year in… Lexicon Pharmaceuticals (LXRX) Q4 Loss Narrows to $0.04 Per Share Despite 79% Revenue Plunge to $5.5M 1 month ago Lexicon narrows Q4 loss to $0.04 per share from $0.09 year-ago, but revenue plunges 79% to $5.5M amid commercialization challenges. Next» « Previous